Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-04013-xWe must build safeguards against AI’s most dangerous feature: its ability to stop
Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-04002-0The first-in-human trial of AAV2i8-I1c (AB-1002) — an adenovirus vector that targets a
Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-04002-0The first-in-human trial of AAV2i8-I1c (AB-1002) — an adenovirus vector that targets a
Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-04011-zIn a phase 1 dose-escalation study including 11 patients with heart failure who
Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-04011-zIn a phase 1 dose-escalation study including 11 patients with heart failure who
Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-03969-0In a phase 1 trial, intramuscular injection of synthetic plasmid DNA encoding monoclonal
Three people have been hospitalised in the US after contracting "severe" cases of mpox - despite not having travelled overseas.Health
PHOENIX, Oct. 21, 2025 /PRNewswire/ -- Sixty years ago, the Diane & Bruce Halle Arizona Burn Center began to transform
PHOENIX, Oct. 21, 2025 /PRNewswire/ -- Sixty years ago, the Diane & Bruce Halle Arizona Burn Center began to transform
WASHINGTON, Oct. 21, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September
